| Date Filed | Type | Description |
| 05/15/2023 |
4
| Peacock Jonathan M (Director) has filed a Form 4 on Avantor, Inc.|
Txns:
| Granted 9,808 shares
@ $0 |
|
| 05/16/2022 |
4
| Peacock Jonathan M (Director) has filed a Form 4 on Avantor, Inc.|
Txns:
| Granted 6,693 shares
@ $0 |
|
| 04/05/2022 |
4
| Peacock Jonathan M (Director) has filed a Form 4 on Avantor, Inc.|
Txns:
| Granted 1,215 shares
@ $0 |
|
| 04/02/2021 |
4
| Peacock Jonathan M (Director) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 15,308 shares
@ $0 |
|
| 03/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/27/2020 |
4
| Peacock Jonathan M (Director) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 350,000 shares
@ $0 |
|
| 05/23/2019 |
4
| Peacock Jonathan M (Director) has filed a Form 4 on Avantor, Inc.|
Txns:
| Granted 14,286 shares
@ $0
Exercised 1,000 options to buy
@ $0 |
|
| 05/23/2019 |
3/A
| Peacock Jonathan M (Director) has filed a Form 3/A on Avantor, Inc. |
| 05/22/2019 |
4
| Peacock Jonathan M (Director) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Bought 20,000 shares
@ $0.6099, valued at
$12.2k
|
|
| 05/16/2019 |
3
| Peacock Jonathan M (Director) has filed a Form 3 on Avantor, Inc. |
| 01/25/2019 |
4
| Peacock Jonathan M (Director) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Bought 714,286 shares
@ $0.7, valued at
$500k
|
|
| 01/25/2019 |
4
| Peacock Jonathan M (Director) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 227,273 shares
@ $0 |
|
| 04/03/2018 |
4
| Peacock Jonathan M (Director) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 99,010 shares
@ $0 |
|
| 10/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2017 |
4
| Peacock Jonathan M (Director) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Bought 248,962 shares
@ $0
Bought 248,962 warrants
@ $1.242, valued at
$309.2k
|
|
| 09/26/2017 |
4
| Peacock Jonathan M (Director) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $1.12, valued at
$11.2k
|
|
| 06/30/2017 |
4
| Peacock Jonathan M (Director) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 57,972 shares
@ $0 |
|
| 06/22/2017 |
4
| Peacock Jonathan M (Director) has filed a Form 4 on Kite Pharma, Inc.|
Txns:
| Granted 2,410 shares
@ $0
Granted 8,810 options to buy
@ $91.21, valued at
$803.6k
|
|
| 12/09/2016 |
4
| Peacock Jonathan M (Director) has filed a Form 4 on Bellerophon Therapeutics, Inc. |
| 11/30/2016 |
4
| Peacock Jonathan M (Director) has filed a Form 4 on Bellerophon Therapeutics, Inc. |
| 06/03/2016 |
4
| Peacock Jonathan M (Director) has filed a Form 4 on Kite Pharma, Inc. |
| 05/18/2016 |
4
| Peacock Jonathan M (President and CEO) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Bought 5,000 shares
@ $1.3683, valued at
$6.8k
|
|
| 01/27/2016 |
4
| Peacock Jonathan M (President and CEO) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 165,975 shares
@ $0 |
|
| 12/17/2015 |
4
| Peacock Jonathan M (President and CEO) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Bought 7,500 shares
@ $2.72, valued at
$20.4k
Bought 12,800 shares
@ $2.7606, valued at
$35.3k
|
|
| 08/20/2015 |
4
| Peacock Jonathan M (President and CEO) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Bought 5,000 shares
@ $5.4754, valued at
$27.4k
|
|
| 06/17/2015 |
4
| Peacock Jonathan M (Director) has filed a Form 4 on Kite Pharma, Inc.|
Txns:
| Granted 10,000 options to buy
@ $59.23, valued at
$592.3k
|
|
| 05/22/2015 |
4
| Peacock Jonathan M (President and CEO) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Bought 5,560 shares
@ $8.6912, valued at
$48.3k
|
|
| 03/16/2015 |
4
| Peacock Jonathan M (President and CEO) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 16,000 options to buy
@ $10.22, valued at
$163.5k
Granted 60,000 options to buy
@ $10.22, valued at
$613.2k
|
|
| 02/23/2015 |
4
| Peacock Jonathan M (President and CEO) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Bought 20,800 shares
@ $12, valued at
$249.6k
|
|
| 06/27/2014 |
4
| Peacock Jonathan M (Director) has filed a Form 4 on Kite Pharma, Inc.|
Txns:
| Acquired 66,014 shares
@ $15.3, valued at
$1M
|
|
| 10/29/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/29/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/01/2012 |
4
| Peacock Jonathan M (EVP & CFO) has filed a Form 4 on AMGEN INC|
Txns:
| Granted 8,654 shares
@ $0 |
|
|